Tobacco carcinogen metabolites and DNA adducts as biomarkers in Head and Neck cancer: Potential screening tools and prognostic indicators

Head and neck squamous cell carcinoma (HNSCC) is one of many cancers that are strongly associated with tobacco use. Whereas HNSCC is often seen in tobacco users, many tobacco users do not develop carcinoma; and the differences between smokers with and without HNSCC are poorly studied to date. Some smokers may be inherently more susceptible to developing carcinoma due to patterns of tobacco use, innate metabolism of carcinogens, or altered excretion. Identifying those smokers at greatest risk for HNSCC would have great benefit through targeted smoking cessation efforts and enhanced surveillance. One approach to better understand the extent of exposure to, and metabolism of, tobacco carcinogens is through the use of tobacco‐specific metabolites. Tobacco‐specific metabolites can identify patterns of dose, exposure, and metabolism, and perhaps ultimately characterize the important differences between smokers who develop HNSCC and smokers who do not. © 2011 Wiley Periodicals, Inc. Head Neck, 2012

[1]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[2]  Jian-Min Yuan,et al.  Applying tobacco carcinogen and toxicant biomarkers in product regulation and cancer prevention. , 2010, Chemical research in toxicology.

[3]  A. Zuckerman,et al.  IARC Monographs on the Evaluation of Carcinogenic Risks to Humans , 1995, IARC monographs on the evaluation of carcinogenic risks to humans.

[4]  A. Malarcher,et al.  Cigarette smoking among adults and trends in smoking cessation - United States, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[5]  K. Straif,et al.  A review of human carcinogens--Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. , 2009, The Lancet. Oncology.

[6]  S. Hecht,et al.  Clear differences in levels of a formaldehyde-DNA adduct in leukocytes of smokers and nonsmokers. , 2009, Cancer research.

[7]  Jian-Min Yuan,et al.  Urinary levels of tobacco-specific nitrosamine metabolites in relation to lung cancer development in two prospective cohorts of cigarette smokers. , 2009, Cancer research.

[8]  D. Hatsukami,et al.  Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers. , 2009, Chemical research in toxicology.

[9]  L. Knudsen,et al.  Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies--a review. , 2008, International journal of hygiene and environmental health.

[10]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[11]  C. Tsien,et al.  EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  A. Cmelak,et al.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. , 2008, Journal of the National Cancer Institute.

[13]  S. Hecht,et al.  Progress and challenges in selected areas of tobacco carcinogenesis. , 2008, Chemical research in toxicology.

[14]  S. Hecht,et al.  Development of liquid chromatography electrospray ionization tandem mass spectrometry methods for analysis of DNA adducts of formaldehyde and their application to rats treated with N-nitrosodimethylamine or 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. , 2007, Chemical research in toxicology.

[15]  Kathleen Stratton,et al.  Ending the tobacco problem : a blueprint for the nation , 2007 .

[16]  D. Hatsukami,et al.  Quantitation of an acetaldehyde adduct in human leukocyte DNA and the effect of smoking cessation. , 2007, Chemical research in toxicology.

[17]  C. Husten,et al.  Tobacco use among adults--United States, 2005. , 2006, MMWR. Morbidity and mortality weekly report.

[18]  J. Koopmeiners,et al.  4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol and its Glucuronides in the Urine of Infants Exposed to Environmental Tobacco Smoke , 2006, Cancer Epidemiology Biomarkers & Prevention.

[19]  Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. , 2006, IARC monographs on the evaluation of carcinogenic risks to humans.

[20]  S. Hecht,et al.  Analysis of Total 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanol in Smokers' Blood , 2005, Cancer Epidemiology Biomarkers & Prevention.

[21]  A. Luch.  Polycyclic Aromatic Hydrocarbon-Induced Carcinogenesis – An Introduction , 2005 .

[22]  J. Gills,et al.  Tobacco components stimulate Akt-dependent proliferation and NFkappaB-dependent survival in lung cancer cells. , 2005, Carcinogenesis.

[23]  D. Hatsukami,et al.  Urinary Metabolites of a Tobacco-Specific Lung Carcinogen in Nonsmoking Hospitality Workers , 2005, Cancer Epidemiology Biomarkers & Prevention.

[24]  S. Hecht,et al.  Tobacco-Specific Nitrosamines and Their Pyridine-N-glucuronides in the Urine of Smokers and Smokeless Tobacco Users , 2005, Cancer Epidemiology Biomarkers & Prevention.

[25]  D. Hatsukami,et al.  Similar Uptake of Lung Carcinogens by Smokers of Regular, Light, and Ultralight Cigarettes , 2005, Cancer Epidemiology Biomarkers & Prevention.

[26]  Neal L. Benowitz,et al.  Metabolism and Disposition Kinetics of Nicotine , 2005, Pharmacological Reviews.

[27]  M. Spitz,et al.  Descriptive epidemiology and risk factors for head and neck cancer. , 2004, Seminars in oncology.

[28]  E. Sturgis.  A review of social and behavioral efforts at oral cancer preventions in India , 2004, Head & neck.

[29]  S. Hecht,et al.  Improved method for determination of 1-hydroxypyrene in human urine. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  D. Hatsukami,et al.  Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen. , 2004, Journal of the National Cancer Institute.

[31]  J Smith,et al.  Tobacco and cancer: recent epidemiological evidence. , 2004, Journal of the National Cancer Institute.

[32]  M. Thun,et al.  Tobacco smoke and involuntary smoking. , 2004, IARC monographs on the evaluation of carcinogenic risks to humans.

[33]  S. Hecht,et al.  Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[34]  Stephen S. Hecht,et al.  Tobacco carcinogens, their biomarkers and tobacco-induced cancer , 2003, Nature Reviews Cancer.

[35]  S. Hecht,et al.  Reactions of formaldehyde plus acetaldehyde with deoxyguanosine and DNA: formation of cyclic deoxyguanosine adducts and formaldehyde cross-links. , 2003, Chemical research in toxicology.

[36]  Alicia Samuels,et al.  Cancer Statistics, 2003 , 2003, CA: a cancer journal for clinicians.

[37]  S. Hecht,et al.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. , 2002, Carcinogenesis.

[38]  T. Steichen,et al.  An analysis of the mainstream smoke chemistry of samples of the U.S. cigarette market acquired between 1995 and 2000. , 2002, Regulatory toxicology and pharmacology : RTP.

[39]  J. Mackay,et al.  The Tobacco Atlas , 2002 .

[40]  D Hoffmann,et al.  The Less Harmful Cigarette: a Controversial Issue. a Tribute to Ernst L. Wynder , 2000 .

[41]  M. Borgerding,et al.  A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (K1R4F and K1R5F). , 2000, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[42]  S. Hecht,et al.  Tobacco smoke carcinogens and lung cancer. , 1999, Journal of the National Cancer Institute.

[43]  J. Pintos,et al.  Effect of smoking cessation and tobacco type on the risk of cancers of the upper aero-digestive tract in Brazil. , 1999, Epidemiology.

[44]  S. Hecht,et al.  Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. , 1998, Chemical research in toxicology.

[45]  J. Mindell.  Tobacco or health: a global status report. , 1998 .

[46]  H Schultz,et al.  Tobacco or health: A global status report. , 1998, Annals of Saudi medicine.

[47]  H. Bartsch,et al.  Tobacco-specific nitrosamines , 1996, European Journal of Cancer Prevention.

[48]  R Doll,et al.  Mortality from smoking worldwide. , 1996, British medical bulletin.

[49]  W. Blot,et al.  Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. , 1994, Journal of the National Cancer Institute.

[50]  P. B. Hopkins,et al.  DNA interstrand cross-linking by formaldehyde: nucleotide sequence preference and covalent structure of the predominant cross-link formed in synthetic oligonucleotides , 1993 .

[51]  S. Hecht,et al.  Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine. , 1993, Cancer research.

[52]  D Hoffmann,et al.  The relevance of tobacco-specific nitrosamines to human cancer. , 1989, Cancer surveys.

[53]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[54]  D. Winn,et al.  Smoking and drinking in relation to oral and pharyngeal cancer. , 1988, Cancer research.

[55]  S. Hecht,et al.  Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke. , 1988, Carcinogenesis.

[56]  F. Berrino,et al.  Cancer of the larynx/hypopharynx, tobacco and alcohol: Iarc international case‐control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France) , 1988, International journal of cancer.

[57]  E. C. Hammond,et al.  Smoking and death rates—report on forty‐four months of follow‐up of 187,783 men , 1988 .

[58]  D. Lisk,et al.  Toxic and carcinogenic agents in dry and moist snuff. , 1987, Journal of the National Cancer Institute.

[59]  P T Henderson,et al.  1-Hydroxypyrene in human urine after exposure to coal tar and a coal tar derived product , 1985, International archives of occupational and environmental health.

[60]  F. Beland,et al.  Rapid isolation, hydrolysis and chromatography of formaldehyde-modified DNA. , 1998, Journal of chromatography.

[61]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[62]  R. Shapiro,et al.  Isolation and identification of cross-links from formaldehyde-treated nucleic acids. , 1980, Biochemistry.

[63]  R. L. Carter,et al.  IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans , 1980, IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans.

[64]  E. C. Hammond,et al.  Smoking and death rates; report on forty-four months of follow-up of 187,783 men. I. Total mortality. , 1958, Journal of the American Medical Association.

[65]  E. C. Hammond,et al.  SMOKING AND DEATH RATES—REPORT ON FORTY-FOUR MONTHS OF FOLLOW-UP OF 187,783 MEN: I. TOTAL MORTALITY , 1958 .

[66]  R. Doll,et al.  Lung Cancer and Other Causes of Death in Relation to Smoking , 1956, British medical journal.

[67]  E. C. Hammond,et al.  Smoking and death rates. , 1954, The South Dakota journal of medicine and pharmacy.

[68]  D HORN,et al.  The relationship between human smoking habits and death rates: a follow-up study of 187,766 men. , 1954 .

[69]  R PerezTamayo,et al.  THE ETIOLOGY OF CANCER , 1932, British medical journal.